Figure 3

The effect of 113 μM I3C, 2.30 μM sorafenib and their combination on (A) caspase-3 and (B) caspase-8 activities. Each point is the mean ± SD of 3 independent experiments. a or b: Significantly different from the control or sorafenib group, respectively, p < 0.05 using ANOVA followed by Tukey–Kramer as post-hoc test.